ENQUIRY
PAY FEES
ANNOUNCEMENTS
Shri Vile Parle Kelavani Mandal's
INSTITUTE OF PHARMACY, DHULE
Approved by PCI, AICTE, DTE
Affiliated to DBATU, Lonere & MSBTE Mumbai
  (02562) 297802, 297602
  iopdhule@svkm.ac.in  
Shri Vile Parle Kelavani Mandal's
INSTITUTE OF PHARMACY, DHULE
Approved by PCI, New Delhi, DTE, Mumbai, Government of Maharashtra
Affiliated to DBATU, Lonere & MSBTE Mumbai

Accredited in 1st cycle with A+ Grade (CGPA 3.43) by NAAC | Accredited by NBA (Diploma Program)
(02562) 297802, 297602   iopdhule@svkm.ac.in  

FACULTY

Dr. Aarti V. Belgamwar

Assistant Professor

Qualification: M. Pharm., Ph.D.

Specialization: Pharmaceutics

Email ID: aarti.belgamwar@svkm.ac.in; aartibelgamwar@yahoo.co.in

Phone: 9822927084

Experience: 17 Years

1.07.2017 to Present
Institute: Shri Vile Parle Kelavani Mandal’s Institute of Pharmacy, Dhule, MH Position: Assistant Professor

1.07.2013 to 30.06.2017
Institute: Institute of Pharmaceutical Education and Research, Wardha, MH
Position: PhD Research Scholar and Principal Investigator on DST WOS A project

17.08.2012 to 30.05.2013
Institute: Dr. R. G. Bhoyar Institute of Pharmaceutical Education and Research, Wardha, MH
Position: Assistant Professor

03.06.2005 to 16.08.2012
Institute: Agnihotri College of Pharmacy, Wardha, MH
Position: Assistant Professor

Interest Areas: Designing and Development of Brain Targeted Nanotherapeutics

Research:

  • Publications:
    • International: (06)
    • National: (03)
  • Books: 1 (In Press)
  • Book Chapters: 05 (03 Published 02 In Press)
  • Patents: 04 (03 granted 01 Published)
  • Presentations:
    • International: (10)
    • National: (08)
  • Guest Lectures Delivered: 04
  • Completed Government Funded Projects: (02)

1. Role: Principal Investigator
Area of Project: Department of Science and Technology WOS-A Project entitled, "Formulation and Characterization of Intranasal Nanoparticles for the CNS Targeting In Neuro-AIDS” (SR/WOS-A/LS-528/2013)
Name of Governing Body: Department of Science and Technology, India

2. Role: Coordinator
Seminar grant
One-day seminar on, "Current Paradigms of Women’s Healthcare”
Name of Governing Body: Maharashtra State Commission for Women

Industry Projects:

  • Completed: (00)
  • Ongoing: (00)

Conferences/Workshops/Seminars attended: (48)

Academic Activities:

  • M. Pharm Guided: (08)
  • B. Pharm Guided: (15)

Awards: Scholarship, Seminar, Workshop, Best Paper, etc.

Scholarship

  • Recipient of DST Woman Scientist Fellowship WOS A (22.75 Lakhs).
  • Recipient of AICTE Post Graduate Scholarship (1.20Lakhs).
  • Recipient of Foundation for Excellence, INC, 3065 Democracy Way, Santa Clara, CA 95054 scholarship in B. Pharm.
  • Recipient of Samaj Sewa Fund, Nagpur, India scholarship in B. Pharm.

Best Paper

  • Received Alexander Fleming Memorial Award for oral talk delivered in "World Congress on Drug Development – 2020” on topic entitled, ‘Intranasal Targeting of Microglial Cells in the Management of Neuro-AIDS’ Organized virtually on 20th December 2020 by ARJYOPA HEALTHCARE conference.
  • Received Prize for best oral presentation in International Conference on ‘New Horizons in the Field of Nanomedicine’ sponsored by Society of Pharmaceutical Education and Research, organized by SVKM’s NMIMS School of Pharmacy & Technology Management, Shirpur, MS, INDIA on 11th Nov 2017 on topic entitled "Intranasal nanosystem for the CNS targeting in Neuro-AIDS”.

Professional Membership: 

  • Life member of Association of Pharmacy Teachers of India (MA/LM-1100)
  • Life Member of Indian Pharmaceutical Association (MAH/DHUL/LM/0039)
  • Registered Pharmacist with Maharashtra State Pharmacy Council (Reg.No.66414)
  • Society of Pharmaceutical Education and Research (SPER) SPER/LM/MH/167

Patents (04)

  • Belgamwar AV, Khan SA, Yeole PG. Intranasal efavirenz nanoparticles for the CNS targeting in NeuroAIDS.
    Application No: 201621041883A
    Journal No: 54/2016; Publication Date: 30/12/2016
    Patent No. 334352
    Status: Granted on 11/03/2020
  • Belgamwar AV, Khan SA, Yeole PG. Synthesis of chitosan-graft- HPβCD copolymer by one pot synthesis technique for solubility enhancement of efavirenz.
    Application No: 3445/MUM/2015
    Journal No: 45/2015; Publication Date: 06/11/2015
    Patent No. 359346
    Status: Granted on 24/02/2021
  • Belgamwar AV, Khan SA, Yeole PG. Intranasal nanocomposite of dolutegravir for the CNS delivery.
    Application No.201721004980 A
    Publication Date : 07/04/2017
    Patent No. 391669
    Status: Granted on 10/03/2022
  • Belgamwar AV, Siddique Mohd Usman, Bawane PP, Ansari AZ. Intranasal nanoparticles of Cink4T for high-grade glioblastoma and method of preparation thereof.
    Application No: 202121005173
    Date of Filing: 06/02/2021 Status: Filed

Recent Publications:

  • Belgamwar A, Khan S, Yeole P. Intranasal dolutegravir sodium loaded nanoparticles of hydroxypropyl-beta-cyclodextrin for brain delivery in Neuro-AIDS. Journal of Drug Delivery Science and Technology. Volume 52, August 2019, Pages 1008-1020 (IF 3.92)
  • Belgamwar A, Khan S, Yeole P. Intranasal chitosan-g-HPβCD nanoparticles of efavirenz for the CNS targeting. Artificial cells, Nanomedicine, and Biotechnology, 2018. 46:2;374-386. (IF 5.678)
  • Belgamwar A, Khan S, Rathi L. Synthesis of chitosan-graft-HPβCCD copolymer by novel one pot technique and its application for solubility enhancement of efavirenz. Journal of Young Pharmacist, 2017; 9(2): 172-176.
  • Landge PP, Belgamwar AV, Mundhada DR. Formulation and evaluation of bucoadhesive tablet of granisetron hydrochloride using natural polymer. International Journal of Pharmacy and Technology. IJPT/April-2013, Vol.5, Issue No. 1: 5156-5164.
  • Gupta AM, Belgamwar AV, Wake PS, Rathi TP, Mundhada DR. Design and development of hydrodynamically balanced tablet of itopride. Journal of Chemical and Pharmaceutical Research. 2011; 3(6): 856-864.
  • Belgamwar AV, Gupta AM, Belgamwar VS, Kawtikwar PS, Mundhada DR. Antiepileptic sustained release carbamazepine microcapsules for kids. International Journal of Pharmaceutical Sciences Review and Research. March-April 2011; 7(2) Article- 028; 154-158.
  • Belgamwar VS, Kawtikwar PS, Phutane GP, Belgamwar A V, Design and evaluation of microcapsules containing Ciprofloxacin hydrochloride for sustained release, Indian drugs 2008 , Vol45(7), 553-557.
  • Belgamwar AV, Gupta AM, Mundhada DR. Fast release carbamazepine tablet for kids. The Indian Pharmacist. Sept. 2007; 6(63); 67-70.
  • Belgamwar AV, Dhole SM, Shende PK, Mundhada DR. A comparative evaluation of different commercial brands of diclofenac tablet. The Indian Journal of Hospital Pharmacy. Jan-Feb 2007

Book chapter (05)

  • Khan SA, Belgamwar AV, Yeole PG. Nanoformulated Vaccines Against Viral Infection: A Review pp315-328
    Book: Nanotechnological solutions for viruses
    Publisher: Wiley (ISBN: 9780323995979)
  • Belgamwar AV, Khan SA, Yeole PG. Nanomedicines for Improved Antiretroviral Therapy in Neuro-AIDS pp 241-266.
    In: Nanobiotechnology in Neurodegenerative diseases. Published by Springer, (Print ISBN 978-3-030-30929-9).
  • Khan SA, Belgamwar AV, Yeole PG. Nanopharmaceuticals for the Improved Treatment of Cerebral Stroke pp 369-385.
    In: Nanobiotechnology in Neurodegenerative diseases. Published by Springer, (Print ISBN 978-3-030-30929-9).
  • Belgamwar AV, Khan SA, Rai Mahendra. Drug Targeting: Nanotechnology Principles, Future Perspectives and Challenges.
    In: Nanotechnology Principles in Drug Targeting and Diagnosis
    Publisher: Elsevier (In Press)
  • Khan SA, Belgamwar AV. Identifying Nanocarrier-Target Interaction
    In: Nanotechnology Principles in Drug Targeting and Diagnosis
    Publisher: Elsevier (In Press)
  • Book

    Nanotechnology Principles in Drug Targeting and Diagnosis
    Publisher: Elsevier (In Press)

    Copyright 2024 SVKM's INSTITUTE OF PHARMACY. All Rights Reserved.   Privacy Policy   Terms of Use
    Admission Enquiry
    Name *
    Email *
    Mobile *
    Query / Comments *